Aripiprazole: Examining the Clinical Implications of D2 Affinity

被引：0
|
作者：
Anam, Adiba [1 ]
Lynch, Sean [1 ]
Mosharraf, Nafiz [1 ]
Soukas, Chloe [1 ]
Gekhman, Dmitriy [1 ,2 ]
机构：
[1] Mt Sinai Beth Israel, Dept Psychiat, New York, NY USA
[2] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY USA
来源：
CNS SPECTRUMS | 2023年 / 28卷 / 02期
关键词：
D O I：
10.1017/S1092852923001232
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Impact of D2 Receptor Internalization on Binding Affinity of Neuroimaging Radiotracers
    Ningning Guo
    Wen Guo
    Michaela Kralikova
    Man Jiang
    Ira Schieren
    Raj Narendran
    Mark Slifstein
    Anissa Abi-Dargham
    Marc Laruelle
    Jonathan A Javitch
    Stephen Rayport
    Neuropsychopharmacology, 2010, 35 : 806 - 817
  • [32] Impact of D2 Receptor Internalization on Binding Affinity of Neuroimaging Radiotracers
    Guo, Ningning
    Guo, Wen
    Kralikova, Michaela
    Jiang, Man
    Schieren, Ira
    Narendran, Raj
    Slifstein, Mark
    Abi-Dargham, Anissa
    Laruelle, Marc
    Javitch, Jonathan A.
    Rayport, Stephen
    NEUROPSYCHOPHARMACOLOGY, 2010, 35 (03) : 806 - 817
  • [33] Dopamine D2 receptors internalize in their low-affinity state
    Ko, F
    Seeman, P
    Sun, WS
    Kapur, S
    NEUROREPORT, 2002, 13 (08) : 1017 - 1020
  • [34] Affinity of clozapine for dopamine D1 and D2 in the HEK 293 cells
    Faron-Gorecka, A
    Kusmider, M
    Dziedzicka-Wasylewska, M
    PHARMACOLOGICAL REPORTS, 2006, 58 (02) : 314 - 315
  • [35] Pet studies of aripiprazole show high D2/D3 receptor occupancy without EPS
    Yokoi, F
    Grunder, G
    Biziere, K
    Suri, A
    Bramer, S
    Wong, DF
    BIOLOGICAL PSYCHIATRY, 2002, 51 (08) : 17S - 17S
  • [36] Synthesis and characterization of selective dopamine D2 receptor ligands using aripiprazole as the lead compound
    Vangveravong, Suwanna
    Zhang, Zhanbin
    Taylor, Michelle
    Bearden, Melissa
    Xu, Jinbin
    Cui, Jinquan
    Wang, Wei
    Luedtke, Robert R.
    Mach, Robert H.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (11) : 3502 - 3511
  • [37] Discovery research and development history of the dopamine D2 receptor partial agonists, aripiprazole and brexpiprazole
    Kikuchi, Tetsuro
    Maeda, Kenji
    Suzuki, Mikio
    Hirose, Tsuyoshi
    Futamura, Takashi
    McQuade, Robert D.
    NEUROPSYCHOPHARMACOLOGY REPORTS, 2021, 41 (02) : 134 - 143
  • [38] Dopamine D2 receptor gene polymorphisms and clinical response to dopamine D2 receptor antagonists
    Mihara, K
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2002, 17 : S59 - S59
  • [39] D2 or not D2? The gastrectomy question
    Lewis W.G.
    Edwards P.
    Barry J.D.
    Khan S.
    Dhariwal D.
    Hodzovic I.
    Allison M.C.
    Shute K.
    Gastric Cancer, 2002, 5 (1) : 29 - 34
  • [40] Aripiprazole in an Animal Model of Chronic Alcohol Consumption and Dopamine D2 Receptor Occupancy in Rats
    Nirogi, Ramakrishna
    Kandikere, Vishwottam
    Jayarajan, Pradeep
    Bhyrapuneni, Gopinadh
    Saralaya, Ramanatha
    Muddana, Nageswararao
    Abraham, Renny
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2013, 39 (02): : 72 - 79
12345